FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.
about
Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor HypoxiaIt takes two to tango, a dance between the cells of origin and cancer stem cells in the Drosophila larval brainInterplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cellsOSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma.Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinomaRecurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinomaTransient Expression of Fez Family Zinc Finger 2 Protein Regulates the Brn3b Gene in Developing Retinal Ganglion Cells.Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.Excavation of attractor modules for nasopharyngeal carcinoma via integrating systemic module inference with attract method.Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.RNA-Sequencing Analysis Reveals a Regulatory Role for Transcription Factor Fezf2 in the Mature Motor Cortex.PBRM1 restricts the basal activity of innate immune system through repressing RIG-I-like receptor signaling and is a potential prognostic biomarker for colon cancer.AIRE: a missing link to explain female susceptibility to autoimmune diseases.Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling.
P2860
Q26783014-814A69E9-00B8-444C-8D8A-844271B2A101Q26864457-7A7D76C0-07F9-4C05-92AB-AC56CDFCA1E1Q33674025-E260D6B1-6194-4232-8D9F-86886527CC32Q33728210-E6F70BDF-04B7-4B49-9A28-D0C8C396668FQ34050917-715466D3-6E72-44A7-AE6F-B801DC851F14Q36211300-908C95AA-ED14-4285-B221-A63FB482F0F8Q36755088-B7B58D23-E4F9-4302-A6C6-2A5A7387F512Q37099828-8417C25F-AD1B-45D0-B819-1347515AE803Q37225359-B469FBA1-C4CD-49C3-8B8E-356881409314Q37709397-3BC4BE9A-AD0C-487A-AE05-03A4ED315DDCQ38682633-2A444754-E9DA-49E6-A0C3-1EEB89D5DAFDQ38774648-E83098A0-919D-47D4-986B-69BCA5E5E4A0Q38931940-FDCEC3D0-5548-43E3-BFE1-B32B76849D99Q41313646-772C3B86-A56F-4D55-AF33-11EEF4D409E9Q41931705-DC3C2DA3-1237-4C9A-92CA-399602A697F6Q47227251-003AEFBC-62B7-4719-B5F0-EADFDA2A5CFAQ49986892-3BD3E5C2-E834-4360-99E0-6C7279F8DCB6
P2860
FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
FEZF2, a novel 3p14 tumor supp ...... d in nasopharyngeal carcinoma.
@en
FEZF2, a novel 3p14 tumor supp ...... d in nasopharyngeal carcinoma.
@nl
type
label
FEZF2, a novel 3p14 tumor supp ...... d in nasopharyngeal carcinoma.
@en
FEZF2, a novel 3p14 tumor supp ...... d in nasopharyngeal carcinoma.
@nl
prefLabel
FEZF2, a novel 3p14 tumor supp ...... d in nasopharyngeal carcinoma.
@en
FEZF2, a novel 3p14 tumor supp ...... d in nasopharyngeal carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
FEZF2, a novel 3p14 tumor supp ...... d in nasopharyngeal carcinoma.
@en
P2093
Anthony T C Chan
Jianming Ying
Mingfang Ji
Sai Wah Tsao
Xiaodong Liu
Xing-Sheng Shu
Yichao Fan
P2860
P304
P356
10.1093/CARCIN/BGT165
P407
P577
2013-05-14T00:00:00Z